Biotechnology VALUE FUND L P, 10% Owner at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 743,128 shares at $10.70 ($8.0M) on 2019-06-10, disclosed to the SEC on 2019-06-12.
Open-market sale of $8.0M CNCE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.70 | 29,450 | $315K | 4.0% |
| 2 | $10.70 | 158,583 | $1.7M | 21.3% |
| 3 | $10.70 | 158,583 | $1.7M | 21.3% |
| 4 | $10.70 | 198,256 | $2.1M | 26.7% |
| 5 | $10.70 | 198,256 | $2.1M | 26.7% |
| Total | $10.70 avg | 743,128 |
| $8.0M |
| 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |